Biosimilarity Study of Intravenous Recombinant Human Erythropoietin in Healthy Volunteers

NCT04954989 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

52

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

BIOLOGICAL: Experimental Erythropoietin subcutaneous injection single dose of 4,000 IU
BIOLOGICAL: Active comparator Erythropoietin subcutaneous injection single dose of 4,000 IU

Sponsor

Megalabs